Renovis
Renovis Renovis is a biopharmaceutical company developing
drugs to treat neurological diseases and disorders. Renovis' current focus is
on research and development programs in the areas of neuroprotection, pain, and
neuroinflammatory diseases. Their most advanced candidate is Cerovive®,
an intravenous drug being evaluated for the treatment of acute ischemic stroke
Cerovive for the treatment of acute ischemic stroke
REN-1654 l for the treatment of sciatica, a form of neuropathic pain REN-850
for the treatment of multiple sclerosis and other autoimmune diseases
More
About Renovis